Modulation of the Cardiovascular Risk in Type 1 Diabetic Rats by Endurance Training in Combination with the Prebiotic Xylooligosaccharide
International Journal of Molecular Sciences · 18.09.2024 · 25 (18) · 10027
DOI: 10.3390/ijms251810027 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.09.2024. Verfasst von Mariya Choneva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Rats, Wistar, Oligosaccharides, Physical Conditioning, Animal, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Plovdiv.
Abstract (Originalsprache)
Diabetic cardiomyopathy is a major etiological factor in heart failure in diabetic patients, characterized by mitochondrial oxidative metabolism dysfunction, myocardial fibrosis, and marked glycogen elevation. The aim of the present study is to evaluate the effect of endurance training and prebiotic xylooligosaccharide (XOS) on the activity of key oxidative enzymes, myocardial collagen, and glycogen distribution as well as some serum biochemical risk markers in streptozotocin-induced type 1 diabetic rats. Male Wistar rats (n = 36) were divided into four diabetic groups (n = 9): sedentary diabetic rats on a normal diet (SDN), trained diabetic rats on a normal diet (TDN), trained diabetic rats on a normal diet with an XOS supplement (TD-XOS), and sedentary diabetic rats with an XOS supplement (SD-XOS). The results show that aerobic training managed to increase the enzyme activity of respiratory Complex I and II and the lactate dehydrogenase in the cardiomyocytes of the diabetic rats. Furthermore, the combination of exercise and XOS significantly decreased the collagen and glycogen content. No significant effects on blood pressure, heart rate or markers of inflammation were detected. These results demonstrate the beneficial effects of exercise, alone or in combination with XOS, on the cardiac mitochondrial enzymology and histopathology of diabetic rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Anatomy, Histology and Embryology, Faculty of Medicine, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Physiology, Faculty of Medicine, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
ORCID-Profile: Mariya Choneva, Slavi Delchev, Iliyan Dimitrov, Mariana Bacelova, Anelia Bivolarska
Förderung
- Medical University of Plovdiv
Zitieren
APA
Choneva, M., Delchev, S., Hrischev, P., Dimov, I., Boyanov, K., Dimitrov, I., Gerginska, F., Georgieva, K., Bacelova, M., & Bivolarska, A. (2024). Modulation of the Cardiovascular Risk in Type 1 Diabetic Rats by Endurance Training in Combination with the Prebiotic Xylooligosaccharide. International Journal of Molecular Sciences, 25(18), 10027. https://doi.org/10.3390/ijms251810027
Vancouver
Choneva M, Delchev S, Hrischev P, Dimov I, Boyanov K, Dimitrov I, et al. Modulation of the Cardiovascular Risk in Type 1 Diabetic Rats by Endurance Training in Combination with the Prebiotic Xylooligosaccharide. International Journal of Molecular Sciences. 2024;25(18):10027. doi:10.3390/ijms251810027
BibTeX
@article{Choneva2024,
author = {Choneva, Mariya and Delchev, Slavi and Hrischev, Petar and Dimov, Ivica and Boyanov, Krasimir and Dimitrov, Iliyan and Gerginska, Fanka and Georgieva, Katerina and Bacelova, Mariana and Bivolarska, Anelia},
title = {Modulation of the Cardiovascular Risk in Type 1 Diabetic Rats by Endurance Training in Combination with the Prebiotic Xylooligosaccharide},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {10027},
doi = {10.3390/ijms251810027}
}
EUVIMED